指南与共识流行病学与生物统计医学教育与科研方法

USPSTF 建议:筛查糖尿病前期与 2 型糖尿病

Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement.
指南 / 共识 · JAMA · 2021-01-01

USPSTF 基于系统综述更新 2015 年建议,针对 35 至 70 岁超重或肥胖且无症状的非妊娠成人,中等确定性认为筛查糖尿病前期和 2 型糖尿病并提供或转介有效预防干预具有中等净获益,给出 B 级推荐。

要点

  • 对 35 至 70 岁超重或肥胖的无症状非妊娠成人筛查糖尿病前期和 2 型糖尿病(B 推荐)。
  • 对糖尿病前期患者应提供或转介至有效的预防干预。
  • 筛查目的是通过早期发现、诊断和治疗改善健康结局。

核心结论

  • USPSTF 以中等确定性认为筛查糖尿病前期和 2 型糖尿病并提供或转介预防干预具有中等净获益。
  • 推荐对 35 至 70 岁超重或肥胖成人筛查糖尿病前期和 2 型糖尿病(B 推荐)。
  • 临床医生应为糖尿病前期患者提供或转介至有效预防干预。

研究设计与样本

  • USPSTF 委托系统综述以更新 2015 年建议,评估无症状非妊娠成人筛查及糖尿病前期预防干预。

主要发现

  • 估计 13% 的美国成人(18 岁及以上)患有糖尿病,34.5% 符合糖尿病前期标准。
  • 糖尿病前期和糖尿病患病率在老年人中更高。
  • 从糖尿病前期进展为糖尿病的风险估计差异很大,可能与定义差异或异质性有关。
  • 糖尿病是美国成人肾衰竭和新增失明病例的主要原因,并与心血管疾病、非酒精性脂肪性肝病和非酒精性脂肪性肝炎风险增加相关。
  • 糖尿病估计为 2017 年美国第七大死因。

关键数值与推荐

  • 推荐在 35 至 70 岁超重或肥胖(BMI 分别 ≥25 和 ≥30)且无症状的非妊娠成人中筛查糖尿病前期和 2 型糖尿病(B 推荐)。
  • 对糖尿病前期患者应提供或转介至有效的预防干预。

临床怎么用

  • 在初级保健中对 35 至 70 岁超重或肥胖且无糖尿病症状的非妊娠成人开展糖尿病前期和 2 型糖尿病筛查。
  • 发现糖尿病前期后,应提供或转介至有效的预防干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: An estimated 13% of all US adults (18 years or older) have diabetes, and 34.5% meet criteria for prediabetes. The prevalences of prediabetes and diabetes are higher in older adults. Estimates of the risk of progression from prediabetes to diabetes vary widely, perhaps because of differences in the definition of prediabetes or the heterogeneity of prediabetes. Diabetes is the leading cause of kidney failure and new cases of blindness among adults in the US. It is also associated with increased risks of cardiovascular disease, nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis and was estimated to be the seventh leading cause of death in the US in 2017. Screening asymptomatic adults for prediabetes and type 2 diabetes may allow earlier detection, diagnosis, and treatment, with the ultimate goal of improving health outcomes. OBJECTIVE: To update its 2015 recommendation, the USPSTF commissioned a systematic review to evaluate screening for prediabetes and type 2 diabetes in asymptomatic, nonpregnant adults and preventive interventions for those with prediabetes. POPULATION: Nonpregnant adults aged 35 to 70 years seen in primary care settings who have overweight or obesity (defined as a body mass index ≥25 and ≥30, respectively) and no symptoms of diabetes. EVIDENCE ASSESSMENT: The USPSTF concludes with moderate certainty that screening for prediabetes and type 2 diabetes and offering or referring patients with prediabetes to effective preventive interventions has a moderate net benefit. CONCLUSIONS AND RECOMMENDATION: The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity. Clinicians should offer or refer patients with prediabetes to effective preventive interventions. (B recommendation).

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Davidson KW, Barry MJ, Mangione CM, et al. Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA. 2021. PMID: 34427594. doi:10.1001/jama.2021.12531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。